Stifel Financial Corp Avidity Biosciences, Inc. Transaction History
Stifel Financial Corp
- $93.7 Billion
- Q4 2024
A detailed history of Stifel Financial Corp transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Stifel Financial Corp holds 6,949 shares of RNA stock, worth $231,401. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,949
Previous 8,012
13.27%
Holding current value
$231,401
Previous $367,000
44.96%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding RNA
# of Institutions
257Shares Held
100MCall Options Held
517KPut Options Held
717K-
Price T Rowe Associates Inc Baltimore, MD11MShares$368 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.43MShares$314 Million0.0% of portfolio
-
Black Rock Inc. New York, NY8.62MShares$287 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.93MShares$264 Million3.76% of portfolio
-
Avoro Capital Advisors LLC New York, NY7.5MShares$250 Million3.18% of portfolio
About Avidity Biosciences, Inc.
- Ticker RNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,127,000
- Market Cap $1.74B
- Description
- Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...